Tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop ...

In the current global market landscape, volatility has been a significant theme, with U.S. stocks experiencing fluctuations due to competitive pressures in the tech sector and ongoing geopolitical ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

The BioSecure Act seeks to reduce US-China biotech ties, creating potential for India to become a biomanufacturing hub.

A PAT roadmap should address data analysis, aggregation, visualization, and the smart utility of those data for greater process understanding.

Request To Download Free Sample of This Strategic Report @ Driving Forces of Growth: The growth of the pharmaceutical analytical testing outsourcing market in Europe is propelled by several key ...

Request To Download Free Sample of This Strategic Report @ Driving Forces Behind the Growth: The robust growth of the Asia Pacific pharmaceutical analytical testing outsourcing market is propelled by ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...